Search
Add filters:
Use filters to refine the search results.
Results 1-7 of 7 (Search time: 0.017 seconds).
- previous
- 1
- next
Item hits:
| Issue Date | Title | Author(s) |
|---|---|---|
| Dec-2022 | HER2DX ERBB2 mRNA expression in advanced HER2- positive breast cancer treated with T-DM1 | Brasó Maristany, Fara; Griguolo, Gaia; Chic, Núria; Pascual, Tomás; Paré Brunet, Laia; Maues, Julia; Galván, Patricia; Dieci, Maria Vittoria; Miglietta, Federica; Giarratano, Tommaso; Martínez Sáez, Olga; Marín Aguilera, Mercedes; Schettini, Francesco; Conte, Benedetta; Angelats, Laura; Vidal Losada, Maria Jesús; Adamo, Barbara; Muñoz, Montse; Sanfeliu, Esther; González Farré, Blanca; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S.; Perou, Charles M.; Conte, Pierfranco; Prat Aparicio, Aleix; Guarneri, Valentina |
| 8-Aug-2022 | Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment | Gianni, Caterina; Palleschi, Michela; Schepisi, Giuseppe; Casadei, Chiara; Bleve, Sara; Merloni, Filippo; Sirico, Marianna; Sarti, Samanta; Cecconetto, Lorenzo; Di Menna, Giandomenico; Schettini, Francesco; De Giorgi, Ugo |
| 8-Nov-2022 | Intrinsic Subtypes and Therapeutic Decision-Making in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer with Visceral Crisis: A Case Report | Schettini, Francesco; Seguí, Elia; Conte, Benedetta; Sanfeliu, Esther; González Farré, Blanca; Jares Gerboles, Pedro; Vidal i Sicart, Sergi; Ganau, Sergi; Cebrecos, Isaac; Brasó Maristany, Fara; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix; Vidal Losada, Maria Jesús |
| 1-Aug-2020 | Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer A Phase 1 and Randomized Phase 2 Trial | Cortés, Javier; Dieras, Veronique; Lorenzen, Sylvie; Montemurro, Filippo; Riera-Knorrenschild, Jorge; Thuss-Patience, Peter; Allegrini, Giacomo; Laurentiis, Michele De; Lohrisch, Caroline; Oravcova, Eva; Pérez García, José Manuel; Ricci, Francesco; Sakaeva, Dina; Serpanchy, Rosanne; Sufliarsky, Jozef; Vidal Losada, Maria Jesús; Irahara, Natsumi; Wohlfarth, Christine; Aout, Mounir; Gelmon, Karen |
| 1-Dec-2020 | Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial | López Miranda, Elena; Pérez García, José Manuel; Cosimo, Serena Di; Brain, Etienne; Ravnik, Maja; Escrivá de Romaní, Santiago; Vidal Losada, Maria Jesús; Gligorov, Joseph; Borstnar, Simona; Calabuig, Laura; Sampayo-Cordero, Miguel; Malfettone, Andrea; Llombart Cussac, Antonio; Suter, Thomas M.; Cortés, Javier |
| 9-Dec-2022 | Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancer | Falato, Claudette; Schettini, Francesco; Pascual, Tomás; Brasó Maristany, Fara; Prat Aparicio, Aleix |
| 28-Sep-2022 | Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer | Schettini, Francesco; Venturini, Sergio; Giuliano, Mario; Lambertini, Matteo; Pinato, David J.; Onesti, Concetta Elisa; De Placido, Pietro; Harbeck, Nadia; Lüftner, Diana; Denys, Hannelore; Van Dam, Peter; Arpino, Grazia; Zaman, Khalil; Mustacchi, Giorgio; Gligorov, Joseph; Awada, Ahmad; Campone, Mario; Wildiers, Hans; Gennari, Alessandra; Tjan-Heijnen, Vivianne; Bartsch, Rupert; Cortés, Javier; Paris, Ida; Martín, Miguel; De Placido, Sabino; Del Mastro, Lucia; Jerusalem, Guy; Curigliano, Giuseppe; Prat Aparicio, Aleix; Generali, Daniele |